Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
Go back to Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk| (NASDAQ: MDGL) | Delayed: 512.88 +7.13 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $505.75 | 52 Week High | $18.24 | |||
| Open | $513.23 | 52 Week Low | $6.60 | |||
| Day High | $517.54 | P/E | N/A | |||
| Day Low | $500.80 | EPS | $0.00 | |||
| Volume | 281,786 | |||||
